Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV edaravone ...

In a new case study, researchers from North Carolina State University found that a family suffering from illnesses that ...

Scientists from the University of Liverpool, and their global collaborators have highlighted the most effective treatments ...

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into ...

ATLANTA — The Georgia Department of Natural Resources (DNR) has confirmed the state's first case of Chronic Wasting Disease ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, a new study indicates.